多反应性IgM通过经典途径启动PF4/肝素复合物的补体激活
研究探讨肝素暴露后抗体反应启动机制。健康供者血浆加入PF4/肝素后补体激活呈高、中、低反应表型,补体激活与血浆IgM水平强相关(r=0.898;P<.005),与其他Ig同种型无关。多反应性IgM结合PF4/肝素,经经典途径触发补体激活并促进B细胞抗原与补体沉积。
要点
- 健康供者血浆对PF4/肝素的补体激活呈高、中、低反应表型。
- 补体激活与血浆IgM水平强相关(r=0.898;P<.005),与其他Ig同种型无关。
- 多反应性IgM结合PF4/肝素,经经典途径启动补体激活。
核心结论
- 血浆IgM水平差异与PF4/肝素诱导的功能性补体反应相关。
- 多反应性IgM结合PF4/肝素,触发经典补体途径激活,并促进B细胞上抗原与补体沉积。
- 这些发现为肝素诱导的血小板减少症免疫反应演变提供新见解,并可能提供风险生物标志物。
研究设计与样本
- 研究将PF4/肝素加入健康供者血浆,观察补体激活并分析血浆蛋白组学。
- 研究在体外及接受肝素的患者中评估IgM对B细胞补体与抗原沉积的作用。
主要发现
- 健康供者血浆加入PF4/肝素后补体激活呈高、中、低反应表型,差异广泛且稳定。
- 血浆补体激活与IgM水平强相关(r=0.898;P<.005),与其他Ig同种型无关。
- 低反应表型血浆中加入健康供者混合IgM可增强PF4/肝素补体激活,加入单克隆IgM则不能。
- 从血浆去除IgM可消除PF4/肝素诱导的C3c生成。
- 脐血及单克隆多反应性IgM在PF4/肝素存在下可生成C3c;抗C1q抗体可阻止IgM介导的补体激活,提示经典途径参与。
关键数值与推荐
- 补体激活与血浆IgM水平的相关系数r=0.898,P<.005。
- 低反应表型血浆加入健康供者混合IgM可增强补体激活,加入单克隆IgM则不能。
- 抗C1q抗体可阻止IgM介导的PF4/肝素补体激活,提示经典途径参与。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The mechanisms by which exposure to heparin initiates antibody responses in many, if not most, recipients are poorly understood. We recently demonstrated that antigenic platelet factor 4 (PF4)/heparin complexes activate complement in plasma and bind to B cells. Here, we describe how this process is initiated. We observed wide stable variation in complement activation when PF4/heparin was added to plasma of healthy donors, indicating a responder "phenotype" (high, intermediate, or low). Proteomic analysis of plasma from these healthy donors showed a strong correlation between complement activation and plasma immunoglobulin M (IgM) levels (r = 0.898; P < .005), but not other Ig isotypes. Complement activation response to PF4/heparin in plasma displaying the low donor phenotype was enhanced by adding pooled IgM from healthy donors, but not monoclonal IgM. Depletion of IgM from plasma abrogated C3c generation by PF4/heparin. The complement-activating features of IgM are likely mediated by nonimmune, or natural, IgM, as cord blood and a monoclonal polyreactive IgM generate C3c in the presence of PF4/heparin. IgM facilitates complement and antigen deposition on B cells in vitro and in patients receiving heparin. Anti-C1q antibody prevents IgM-mediated complement activation by PF4/heparin complexes, indicating classical pathway involvement. These studies demonstrate that variability in plasma IgM levels correlates with functional complement responses to PF4/heparin. Polyreactive IgM binds PF4/heparin, triggers activation of the classical complement pathway, and promotes antigen and complement deposition on B cells. These studies provide new insights into the evolution of the heparin-induced thrombocytopenia immune response and may provide a biomarker of risk.
引用
- Khandelwal S, Ravi J, Rauova L, et al. Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway. Blood. 2018. PMID: 30309891. doi:10.1182/blood-2018-03-834598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。